btg plc (BTG:London Stock Exchange)
Guenter R. Janhofer
Head of Development and Chief Medical Officer, BTG plc
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Dr. Guenter R. Janhofer has been Head of Development at BTG plc since joining in March 2009 and has been its Chief Medical Officer since 2011. Mr. Janhofer has more than 25 years of experience in the pharmaceutical industry across all phases of clinical development from Phase I to end-stage life-cycle management and across a wide variety of therapeutic areas, including cardiovascular, metabolic, neuroscience, infectious diseases, respiratory, osteoporosis and oncology. ...
5 Fleet PlacePhone: 44 20 7575 0000
London, Greater London EC4M 7RD
Fax: 44 20 7575 0010
Board Members Memberships*There is no Board Members Memberships data available.
Technische Universität Berlin
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Fred P. Lampropoulos||Chairman, Chief Executive Officer and President|
Merit Medical Systems, Inc.
|Larry Hsu Ph.D.||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|István Hodász||Chief Executive Officer, Managing Director and Director|
EGIS Pharmaceuticals PLC
|Matthew Vella||Chief Executive Officer, President and Director|
Acacia Research Corporation
|Said Samih Taleb Darwazah||Chief Executive Officer and Director|
Hikma Pharmaceuticals plc
|$2.0M||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26